Home Tools
Log in
Cart

Search Result

Search Results for " parkinson's syndrome "

13

Compounds

Cat No. Product Name Synonyms Targets
T1308 Orphenadrine hydrochloride Mebedrol,Mephenamin Sodium Channel , NMDAR , Norepinephrine , iGluR , Histamine Receptor
Orphenadrine hydrochloride (Mephenamin) is a muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
T1476 Pramipexole SND 919 Dopamine Receptor
Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not...
T6618 Orphenadrine Citrate Flexon,Flexoject,Banflex AChR , iGluR
Orphenadrine Citrate (Flexon) is a skeletal muscle relaxant, it acts in the central nervous system to produce its muscle relaxant effects.
T6951 Pramipexole dihydrochloride hydrate Pramipexole 2HCl Monohydrate,Mirapex Dopamine Receptor
Pramipexole dihydrochloride hydrate (Mirapex) is the hydrochloride salt of pramipexole, a benzothiazole derivative. As a nonergot dopamine agonist, pramipexole binds to D2 and D3 dopamine receptors in the striatum and su...
T68026 (Rac)-GSK 372475 Others
(Rac)-GSK 372475 may be investigated for the treatment of Parkinson's syndrome, depression and obesity.
T22638 CBiPES hydrochloride CBiPES HCl GluR
CBiPES hydrochloride (CBiPES HCl) is a potent orthosteric modulator of the mGlu2 receptor with an EC50 value of 92.8 nM.CBiPES hydrochloride blocks the action of WT and mGlu(3) receptors.CBiPES hydrochloride can be used ...
T28367L1 BDBM50597431 NMDAR
BDBM50597431 is an NMDA receptor modulator that may have can be used to study Alzheimer's disease and Parkinson's syndrome.
T34616 Seridopidine ACR-343,ACR 343,ACR343 Dopamine Receptor
Seridopidine (ACR343) is a modulator of dopaminergic activity that is used as an oral therapy for schizophrenia, Parkinson's disease, and Tourette's syndrome.
T29955 AMC-01 AMC01,AMC 01 Antiviral , PERK
AMC-01 has potential antiviral activity and induces dose- and time-dependent inactivation of eIF2-α via phosphorylation of serine residue 51. AMC-01 can be used to study atherosclerosis and Parkinson's syndrome.
T6552 Istradefylline KW-6002 Adenosine Receptor
Istradefylline (KW-6002)(Ki of 2.2 nM) is a selective adenosine A2A receptor (A2AR) antagonist, which is under development in Phase 3 trails. It has been used in trials studying the treatment and basic science of Drug Ab...
T6651L Safinamide EMD1195686,FCE26743,FCE 26743,EMD-1195686,EMD 1195686,FCE-26743 MAO
Safinamide (FCE-26743) is a reversible and selective monoamine oxidase B (IC50 0.098μM) inhibitor, reducing the degradation of dopamine, and a glutamate release inhibitor (IC50 8μM). It also inhibits dopamine reuptake. S...
T27127 DCAT Maleate DCAT
DCAT Maleate is an inhibitor of N-methyl transferases (NMT). DCAT Maleate methylate non-methylated pre-neurotoxins to prevent the formation of Parkinson's syndrome neurotoxins.
T77995 NNZ 2591
NNZ 2591, a synthetic analogue of cyclic glycine-proline (cGP), exhibits oral activity and the ability to cross the blood-brain barrier. This compound demonstrates neuroprotective properties following ischemic brain inju...
TargetMol